# MFB Fertility

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mfb-fertility

- Industry: Biotechnology
- Headquarters: Boulder, US
- Website: www.proovtest.com
- Total disclosed funding: $9.7M
- Latest round: Series A (Dec 7, 2021)
- Investors on record: 7

## About

Based in Boulder, Colorado, MFB Fertility Inc. specializes in developing at-home fertility and hormone testing solutions that empower women to manage their reproductive health effectively.Founded in 2018, MFB Fertility Inc. focuses on enhancing women's reproductive health through innovative testing products. The company has successfully completed three funding deals, with the most recent being a Series A round on December 7, 2021, raising USD 9.7 mn from multiple investors, including GingerBread Capital and SteelSky Ventures. The founder's history includes expertise in female health technologies, though specific prior ventures are not disclosed.Proov specializes in at-home fertility and hormone testing solutions designed to empower women in managing their reproductive health throughout various life stages, including fertility, perimenopause, and menopause. The company's core offerings include the Proov Complete Fertility Testing System, which provides insights into hormone levels and identifies the fertile window, as well as the Empower Home Hormone Tracker to assess hormonal balance. These products utilize advanced pattern recognition technology to detect subtle hormone shifts, thus addressing common issues such as unexplained infertility, polycystic ovary syndrome (PCOS), and symptoms related to perimenopause. Proov's products are designed for direct-to-consumer sales and have gained a clientele of over 50,000 couples primarily located in the United States, with potential market reach in other regions as awareness of fertility health increases.Proov operates on a direct-to-consumer sales model, offering its products through its online platform. Revenue is generated primarily from individual product sales, including flagship items like the Proov Complete Fertility Testing System and various hormone support supplements. The pricing structure is designed to facilitate accessibility for users seeking to monitor their reproductive health and includes options for one-time purchases and subscription plans for ongoing hormone support. Customers typically engage in transactions by purchasing test kits that combine hormone tracking with detailed insights into their fertility health, thereby enhancing their understanding of ovulation and hormonal balance. The company's commitment to customer satisfaction is reflected in its robust support structure, ensuring users receive the guidance needed to navigate their fertility journeys effectively.Following the recent Series A funding round concluded on December 7, 2021, MFB Fertility Inc. plans to utilize the USD 9.7 mn raised to support the development of its new Complete product, which will feature follicle-stimulating hormone tests alongside multi-hormone tests measuring estrone glucuronide, LH, and PdG. The company is also targeting expansion into international markets, with plans to increase its presence in Europe and Asia by the end of 2023, aiming to reach a broader audience seeking fertility health solutions.

## Funding rounds

- Series A, Dec 7, 2021, $9.7M — Hambrecht Capital, Portfolia, GingerBread Capital, Lightship Capital, SteelSky Ventures, WCC Partners
- Seed, Aug 8, 2018 — Hillman Accelerator

## Investors

- Hillman Accelerator (https://capitalatlas.ai/funds/hillman-accelerator) — Seed
- Hambrecht Capital (https://capitalatlas.ai/funds/hambrecht-capital) — Series A
- Portfolia (https://capitalatlas.ai/funds/portfolia) — Series A
- GingerBread Capital (https://capitalatlas.ai/funds/gingerbread-capital) — Series A
- Lightship Capital (https://capitalatlas.ai/funds/lightship-capital) — Series A
- SteelSky Ventures (https://capitalatlas.ai/funds/steelsky-ventures) — Series A
- WCC Partners — Series A